Artificial Intelligence and Anticancer Drug Development—Keep a Cool Head

Autor:	Caroline Bailleux, Jocelyn Gal, Emmanuel Chamorey, Baharia Mograbi, Gérard Milano
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	serendipity new drug discovery oncology artificial intelligence Pharmacy and materia medica RS1-441
Zdroj:	Pharmaceutics, Vol 16, Iss 2, p 211 (2024)
Druh dokumentu:	article
ISSN:	1999-4923
DOI:	10.3390/pharmaceutics16020211
Popis:	Artificial intelligence (AI) is progressively spreading through the world of health, particularly in the field of oncology. AI offers new, exciting perspectives in drug development as toxicity and efficacy can be predicted from computer-designed active molecular structures. AI-based in silico clinical trials are still at their inception in oncology but their wider use is eagerly awaited as they should markedly reduce durations and costs. Health authorities cannot neglect this new paradigm in drug development and should take the requisite measures to include AI as a new pillar in conducting clinical research in oncology.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/8950bdaf2f7d4fc3a5fc38e8bfee6352 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.